Michigan Swing Dance

How Cancer Treatment Centers Of America Is Raising Awareness Of Prostate Cancer

About one in seven men in the United States will have a doctor diagnose them with prostate cancer at some point in their lives. The odds are even higher for African American men at one in five. This is the type of cancer that is most common among men. The best time to catch this disease is as early as possible.

In August 2017 three organizations teamed up to raise awareness of prostate cancer and the benefits of an early diagnosis. Among these was the National Football League Alumni Association and Labcorp. The other partner was Cancer Treatment Centers Of America (CTCA). Collectively they ran a campaign that offered men at the most risk, age 40 and above, an exam at one of Labcorp’s national locations. The first 2,000 men that signed up received a free prostate exam while every other eligible man after that had to pay only $25 to receive their exam.

Cancer Treatment Centers of America has been treating patients with cancer since 1988 when it was founded by Richard J Stephenson. The founder had witnessed his mother’s cancer treatment and was very unsatisfied with what he saw. Unfortunately his mother died of cancer and so he dedicated himself to helping others achieve a better outcome.

CTCA is a national organization of hospitals which all specialize in cancer treatment centers. These hospitals are located in Georgia, Arizona, Illinois, Pennsylvania, and Oklahoma. They offer conventional treatments of cancer such as surgery, chemotherapy, and cancer drugs. They also support their patients through the process of being treated for cancer which can be very taxing and worrisome for patients. Many people being treated for cancer find themselves depressed as well as suffering from pain and other side effects. CTCA offers patients ways of dealing with these side effects in a compassionate way.

To Know More Click Here

Erick Lefkofsky Technological Contribution in Battling Breast Cancer

Breast Cancer is a condition affecting many individuals worldwide. It cuts across regions, wealth status and medical advancement levels. Various treatments and interventions have been devised to fight the scourge. Unfortunately, no single method or entity has come up with specific treatment guideline. This gloomy scenario has resulted in more suffering and unnecessary fatalities. As of now, the medical fraternity cannot assure patients of complete breast cancer healing. But behind the scenes, Tempus, the cancer-fighting startup from Groupon founder Erick Lefkofsky is working hard to change this situation.The drawbacks in treating breast cancer arise from the numerous presentations, mutations and personal backgrounds. To tackle the breast cancer menace, Tempus has come up with a strategy to capture data from patients in all health facilities dealing with cancer. In partnership with the University of Chicago, Tempus will analyze data from over 1,000 cancer patients. This statistics will assist doctors in creating personalized treatment for each patient.

Diagnosis of Breast Cancer requires a paradigm that involves targeted therapeutics that exploits the immunological and molecular state of the tumor. Tempus primary focus is to collect and disseminate an acceptable model that doctors can use to match each patient’s molecular profile to their treatment.To realize this noble idea, the Precision Promise trial, organized by the Pancreatic Cancer Action Network (PanCAN) has tapped Tempus to use its disruptive technology in production and analysis of genomic and clinical data. By utilizing Tempus tools, thousands of breast cancer patients’ data will be collected and stored for clinical referencing. Physicians will use this technology in determining the molecular constitution of patient’s cells and focusing therapy on the genomic profile. This targeted treatment is expected to bring positive results to breast cancer patients.

Erick Lefkofsky is the co-founder and CEO of Tempus company. This technological company has created an operating system for collecting and preserving data from cancer patients. He graduated from the University of Michigan and received his Juris Doctor from the Universityof Michigan Law School. Also, he is the co-founder and chairman of Groupon and Uptake technologies.Mr. Lefkofsky together with his wife Liz has established the Lefkofsky Family Foundation. The charitable organization is improving the welfare of people in targeted communities.